CAR T Cell Receptor Immunotherapy Targeting VEGFR2 for Patients With Metastatic Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Metastatic Melanoma
Related studies linked through entity extraction aliases.
Ipilimumab in Patients With Advanced Melanoma and Spontaneous Preexisting Immune Response to NY-ESO-1
- Status
- COMPLETED
- Phase
- PHASE2
Local Modulation of Immune Receptors to Enhance the Response to Dendritic Cell Vaccination in Metastatic Melanoma
- Status
- TERMINATED
- Phase
- PHASE1
A Safety and MORAb-028 Dose Determination Study in Subjects With Metastatic Melanoma
- Status
- TERMINATED
- Phase
- PHASE1
Peptide Vaccination Associated With Tumoral Immunomodulation in Patients With Advanced Metastatic Melanoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Phase II Study of Aldesleukin (IL-2) Following the Administration of Zanolimumab (Anti-CD4mAb) in Metastatic Melanoma and Metastatic Renal Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Ipilimumab With or Without Sargramostim in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Combination Therapy of F16IL2 and Paclitaxel in Solid Tumour Patients
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Ipilimumab + Temozolomide in Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Prospective Randomized Comparative Study of Cell Transfer Therapy Using CD8+-Enriched Short-Term Cultured Anti-Tumor Autologous Lymphocytes Following a Non-Myeloablative Lymphocyte Depleting Chemotherapy Regimen Compared to High-Dose Aldesleukin in M...
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Immunotherapy With TIL (Tumor Infiltrating Lymphocytes) in Combination With Intra-tumoral Injections of Interferon Gamma-adenovirus (Ad-IFNg) in Patients With Stage IIIc or Stage IV Metastatic Melanoma (AJCC)(Protocol TIL-Ad-INFg)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Clinical Study Phase II of L19IL2 in Combination With Dacarbazine in Patients With Metastatic Melanoma
- Status
- TERMINATED
- Phase
- PHASE2
Dendritic Cells (DC) Vaccine for Metastatic Melanoma
- Status
- TERMINATED
- Phase
- PHASE2
Rituximab in Metastatic Melanoma
- Status
- TERMINATED
- Phase
- PHASE1
QUILT-2.008: Study of ALT-801 With Cisplatin in Patients With Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Everolimus With Paclitaxel and Carboplatin in Patients With Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Dose Escalation Study of MLN4924 in Adults With Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
Lymphodepletion Plus Adoptive Cell Transfer With High Dose IL-2 in Patients With Metastatic Melanoma
- Status
- COMPLETED
- Phase
- NA
Temozolomide and Sunitinib Malate in Treating Patients With Stage III or Stage IV Malignant Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Assess PV-10 Chemoablation of Cancer of the Liver
- Status
- UNKNOWN
- Phase
- PHASE1